The facility in Kabul, Afghanistan, is developing into a key factor in the worldwide supply chain for Abacavir Sulphate drug substance. This regional manufacturing capability represents a considerable step ahead for the Afghan pharmaceutical industry and offers a unique opportunity to mitigate reliance on imports. The production of this vital medic